We are sharing Tech and Health related news from all around the world. hope that these content will serve the purpose.
Ozempic among ‘bogus’ drug patents being challenged by U.S. to spur competition
The Federal Trade Commission sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions.
No comments:
Post a Comment